PHARMACIE DU CENTRE
0524.874.720 · rovalta.com · 26/09/2026
PHARMACIE DU CENTRE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPHARMACIE DU CENTRE is a Private limited company incorporated in 2013. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Namur. It employs on average 7,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0524.874.720
- Incorporation
- 27/03/2013
- Legal form
- Private limited company
- Registered office
- Av. du Bourg. Jean Materne(JB) 136
5100 Namur · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 7,9 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 630,7 k € | -18.0% | 768,9 k € | +1.5% | 757,4 k € | +10.1% | 688,1 k € | -4.0% | 716,5 k € |
| EBITDA | 158,7 k € | -46.2% | 294,9 k € | -7.2% | 317,9 k € | +6.8% | 297,6 k € | -15.2% | 351,1 k € |
| Operating result | 71,3 k € | -66.5% | 212,8 k € | -13.4% | 245,8 k € | +2.0% | 241 k € | +0.6% | 239,6 k € |
| Net result | 96,7 k € | -25.3% | 129,5 k € | -24.0% | 170,6 k € | +15.6% | 147,5 k € | +4.8% | 140,7 k € |
| Balance sheet | |||||||||
| Equity | 558,9 k € | -19.1% | 690,8 k € | +5.1% | 657,6 k € | +4.6% | 628,7 k € | -18.8% | 774,6 k € |
| Total assets | 841,7 k € | -42.4% | 1,5 M € | +6.6% | 1,4 M € | +3.9% | 1,3 M € | +9.7% | 1,2 M € |
| Cash | 231,8 k € | -55.2% | 516,9 k € | +80.8% | 285,9 k € | -31.7% | 418,3 k € | -14.9% | 491,8 k € |
| Debts | 267,6 k € | -64.3% | 749,1 k € | +6.3% | 704,4 k € | +2.6% | 686,5 k € | +63.0% | 421,2 k € |
| Other | |||||||||
| Workforce | 7,9 ETP | -7.1% | 8,5 ETP | +4.9% | 8,1 ETP | -5.8% | 8,6 ETP | +17.8% | 7,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 18/06/2026 | 17/06/2025 | 04/06/2024 | 01/06/2023 | 08/06/2022 | 16/08/2021 |
| General meeting | 29/05/2026 | 30/05/2025 | 31/05/2024 | 26/05/2023 | 27/05/2022 | 28/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/05/2026 | 18/06/2026 | French | |
| Abridged model | 31/12/2024 | 30/05/2025 | 17/06/2025 | French | |
| Abridged model | 31/12/2023 | 31/05/2024 | 04/06/2024 | French | |
| Abridged model | 31/12/2022 | 26/05/2023 | 01/06/2023 | French | |
| Abridged model | 31/12/2021 | 27/05/2022 | 08/06/2022 | French | |
| Abridged model | 31/12/2020 | 28/05/2021 | 16/08/2021 | French | |
| Abridged model | 31/12/2019 | 29/05/2020 | 20/07/2020 | French | |
| Abridged model | 31/12/2018 | 31/05/2019 | 12/06/2019 | French | |
| Abridged model | 31/12/2017 | 25/05/2018 | 23/07/2018 | French | |
| Abridged model | 31/12/2016 | 05/05/2017 | 04/08/2017 | French | |
| Abridged model | 31/12/2015 | 27/05/2016 | 31/05/2016 | French | |
| Abridged model | 31/12/2014 | 29/05/2015 | 14/08/2015 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates15/01/2025DEMISSIONS, NOMINATIONS
- Mandates16/05/2024MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Restructuring31/05/2017DENOMINATION - CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring13/03/2017RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Other29/03/2013RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202596,7 k €↓
- 2024Annual accounts 2024129,5 k €↓
- 2023Annual accounts 2023170,6 k €↑
- 2022Annual accounts 2022147,5 k €↑
- 2021Annual accounts 2021140,7 k €↑
- 2020Annual accounts 202088 k €↓
- 2019Annual accounts 201996,3 k €↓
- 2018Annual accounts 2018141,4 k €↓
- 2017Annual accounts 2017300 k €↑
- 2016Annual accounts 201654 k €↑
- 2016Name changePharmacie du Centre
- 2015Annual accounts 201552,8 k €↓
- 2014Annual accounts 201468 k €
- 2014Name changeBRISBOIS INVEST
- 27/03/2013IncorporationPrivate limited company